The Netherlands formed is cis-Pt(NH 3 ) 2 d(GpG) (Pt-GG), with Pt bound to two 6 To whom correspondence should be addressed adjacent guanines. Another major intrastrand crosslink is cisFor the improvement of chemotherapy with platinum Pt(NH 3 ) 2 d(ApG) (Pt-AG), in which the Pt is bound to adenine (Pt)-containing drugs a sensitive assay to detect the induced and an adjacent guanine. The other bifunctional adducts are Pt-DNA adducts is needed. Therefore, the 32 P-postlabelling cis-Pt(NH 3 ) 2 (dG) 2 (G-Pt-G), the intrastrand adducts in which assay, described by Blommaert 
and Saris (Nucleic Acids
Pt is bound to two guanines separated by one or more other Res., 1995, 23, 1300-1306), to detect the major adducts nucleotide(s) and the interstrand crosslinks on two guanines Pt-GG and Pt-AG has substantially been improved and in opposite strands.
compared with ELISA and AAS. For the quantification of
There are several methods to determine the total amount of the adducts, TpT was added as an internal standard Pt-adducts in isolated DNA (3), of which atomic absorption immediately after isolation of the Pt-adducts from digested spectroscopy (AAS) is the most common (4, 5) . Also various DNA samples. It was found that 32 P-labelling of both GpG immunochemical techniques are available using polyclonal antibodies directed against platinated DNA (6) (7) (8) (9) (10) . None of and ApG, the dinucleotides obtained after deplatination of these systems, however, is able to quantify the various DNA the adducts, was equally efficient as that of TpT. To adducts separately. For this purpose an immunochemical isolate the Pt-adducts on basis of a positive charge, the method has been developed by Fichtinger-Schepman and pH of DNA digests was adjusted to~3 prior to separation colleagues (2,11,12), using polyclonal antibodies directed by strong cation-exchange chromatography. For the against the different types of adducts as present in digested subsequent deplatination a volume of only 12 µl of 0.2 M DNA samples (ELISA method). Although this method is very NaCN was used, which did not interfere with the followsensitive, drawbacks are the rather large amounts of DNA ing labelling step. The quantification of the 32 P-labelled needed, the limited availability of the rabbit antisera and the dinucleotides was performed by phosphorimaging of spots fact that these antibodies are only suitable to detect adducts after separation on TLC as well as by 32 P-counting of induced by cisplatin and carboplatin. Also, this method is fractions collected after separation by HPLC. The method rather laborious. was used to determine adduct levels in in vitro cisplatinTherefore, there was a need for a more generally applicable treated DNA and in DNA isolated from cisplatin-treated and sensitive method to determine adduct levels in small cultured cells, tumor xenografts from cisplatin-treated samples of platinated DNA. Such an assay was recently mice, and from white blood cells and (tumor) tissues from developed by Blommaert and Saris (1), using a 32 P-postcisplatin-treated patients. The results show a significant labelling technique. In this assay the DNA is digested, followed correlation with the adduct levels as determined with by isolation of the Pt-adducts on the basis of their positive atomic absorption spectroscopy (high levels) or with specific charge, their deplatination with sodium cyanide (NaCN) and antibodies (low levels). This assay appears to be useful for finally the labelling of the resulting dinucleotides with the determination of low levels of Pt-adducts in small DNA [γ-32 P]ATP. This deplatination appeared to be a crucial step to samples as present in clinical specimens such as blood and enhance the sensitivity of the assay, because the dinucleotides are labelled with a much higher efficiency than the platinated described by Blommaert and Saris (1), reproducible quantita-tive analysis was impossible due to the absence of an internal standard. Furthermore, the recovery of the adducts was only 30%. In the present paper we report on the improvement of the assay by optimizing the isolation of the adducts on the strong cation-exchanger. In addition, an internal standard for the labelling reaction was added and the deplatination step was modified, so that a subsequent purification could be omitted. For the quantification of the 32 P-labelled products thin-layer chromatography (TLC) in combination with phosphorimaging was used, as well as high performance liquid chromatography (HPLC) with 32 P-counting of the collected column fractions. The improved assay was found to be quite suitable to determine adduct levels in in vitro cisplatin-treated DNA, in DNA isolated from cisplatin-treated cultured cells, in DNA from tumor xenografts in mice given cisplatin therapy, as well as in DNA from human white blood cells and (tumor) tissues of cisplatin-treated patients.
Materials and methods

Reference compounds
The dinucleotides GpG, ApG and TpT were purchased from Sigma (St Louis, MO) and dissolved in distilled water. The Pt-GG and Pt-AG adducts were isolated from cisplatin-treated salmon sperm DNA (2) and quantified on the basis of their Pt content by AAS. G-Pt-G was prepared by incubation of deoxyguanosine with cisplatin (2:1 ratio) for 5 h at 50°C in the dark and purified as described by Fichtinger-Schepman and coworkers (15).
Treatment of DNA with cisplatin
Scheme I. A schematic outline of the 32 P-postlabelling assay. The isolated Salmon sperm DNA (Worthington Biochemical Corporation, Freehold, NJ), DNA is digested into unmodified nucleosides (N) and Pt-adducts by the dissolved in 10 mM sodium phosphate pH 7.2 (1 mg/ml), was incubated for enzymes P1-nuclease (P1), DNAse I and alkaline phosphatase (AP) (1). 5 h at 50°C with cisplatin (Platinol, Bristol Myers Squibb B.V., Woerden, Then, the adducts are purified by strong cation-exchange (SCX) The Netherlands) at concentrations ranging between 0 and 42.7 nM. Unbound chromatography (2), and collected in tubes containing NaCN and the and mono-functionally bound cisplatin were inactivated by overnight dialysis internal standard TpT (3a), whereafter the samples are dried in vacuo (3b). against 0.1 M NH 4 HCO 3 at room temperature, followed by dialysis against Subsequently, after addition of NaCN to a total of 12 µl 0.2 M NaCN, the water at 4°C. The amounts of bifunctional adducts Pt-GG and Pt-AG in these adducts are deplatinated by incubation for 2 h at 65°C (3c), whereafter they DNAs were determined by competitive ELISA in the chromatographed, are postlabelled (4), separated and quantified (5). digested samples, as described by Fichtinger-Schepman et al. (12) . An additional DNA sample was incubated with 3.3 µM cisplatin to obtain sufficiently high adduct levels in order to determine these also with AAS medium for several hours, the inactivation step with thiourea was not necessary (16). Furthermore, part of this sample and untreated DNA were postincubated because reactive mono-adducts were no longer present in platinated DNA with 10 mM thiourea (Aldrich Chemie, Steinheim, Germany) for 1 h at 37°C after that period (17). in order to see whether this procedure, introduced recently as an alternative for the NH 4 HCO 3 treatment for the rapid and more reliable inactivation of DNA digestion unbound and mono-functionally bound cisplatin (17), could have an effect on Two methods were applied for the digestion of DNA to deoxynucleosides the postlabelling results.
(see Scheme I, no. 1). First, DNA was digested as described by Blommaert Treatment of cultured cells with cisplatin and Saris (1) with the exception that after the digestion only 1/100 instead of 1/10 volume of 1 M Tris-HCl pH 9.0 was added. This volume was sufficient The IGROV-1 human ovarian carcinoma cell line was originally described by to reach the pH optimum of calf intestinal alkaline phosphatase (Life Benard et al. (18) . Cells were routinely cultured in RPMI 1640 medium with Technologies, Breda, The Netherlands). Under these conditions a complete HEPES (pH 7.4) and phenol red, supplemented with 10% bovine calf serum, digestion of the major intrastrand crosslinks to Pt-GG and Pt-AG dinucleotides 10 mM NaHCO 3 , 2 mM glutamine, gentamycin (45 µg/ml), penicillin (110 IU/ will be obtained (2). ml) and streptomycin (100 µg/ml) in a humidified atmosphere of 5% CO 2 in A second method to digest DNA was by dissolving 10-100 µg DNA in air at 37°C. The cells were frequently monitored for mycoplasm contamination.
50 µl of 50 mM ammonium acetate (NH 4 Ac, pH 5.0) to which 6 units nuclease In order to study the formation of GpG and ApG intrastrand adducts in P1 (Boehringer Mannheim, Germany) and 1 mM ZnCl 2 (pH 8.2) were added. these cells, 10 6 cells were incubated with 0-66.7 µM cisplatin for 2 h at After an incubation at 55°C for 2 h, 10 µl of 1 M Tris-HCl (pH 8.2) with 37°C. Subsequently, medium was removed, cells were washed twice with 10 mM MgCl 2 and 50 units DNAse I (Boehringer) were added, after which phosphate-buffered saline (PBS) and trypsinized. After centrifugation cell the incubation was prolonged for 2 h at 37°C. Finally, 20 units alkaline pellets were stored at -20°C until DNA isolation.
phosphatase (Boehringer) were added, the pH was adjusted to 9.0 and the Treatment of tumors with cisplatin digestion mixture was incubated at 37°C for another 2 h for samples containing Human head and neck squamous cell carcinomas (HNSCC) were grown as Ͻ25 µg, and overnight for samples with more DNA. The efficacy of this xenografts in nude mice (19) . Subsequently, these tumors were treated ex vivo digestion procedure and the amount of DNA were determined by HPLC with 1.7 mM cisplatin for 1 h. To obtain in vivo treated samples, nude mice analysis on a C 18 -column (Inertsil ODS-80A, 150ϫ4.6 mm, 5 µm) eluted bearing human ovarian carcinomas (OVCAR1) were treated intravenously with 0.1 M NH 4 Ac (pH 5.5)/10% MeOH at a flow rate of 1.0 ml/min. In this with 5 mg cisplatin/kg and killed at different time periods after treatment. In system the nucleosides dC, dG, T and dA elute at 2.0, 3.1, 3.9, and 6.1 min, addition to the tumors, liver and kidney tissues also from these mice were respectively. The exact amount of DNA could be calculated from the integrated stored at -20°C until DNA isolation.
dA peak (using ε 260 ϭ 15,400 l/mol/cm).
DNA isolation
Purification and concentration of cisplatin-DNA adducts Separation of the platinated adducts from the unmodified deoxynucleosides DNA was isolated as described previously (12, 17) . For the cisplatin-treated IGROV-1 cells and blood samples from cisplatin-treated patients, the isolation was achieved by strong cation-exchange (SCX) chromatography, either with the strong cation-exchange column Mono-S coupled to an FPLC system procedure with high-salt extraction was used as described by Miller et al. (20) . When cisplatin-containing samples were postincubated in drug-free (Pharmacia Biotech Benelux, Roosendaal, The Netherlands) (Scheme I, no. The 32 P-postlabelling assay to determine the two major PtScience Group, Emmen, The Netherlands). Also GpG and ApG dinucleotides from unplatinated DNA regions, if any present, will be separated from the DNA intrastrand crosslinks Pt-GG and Pt-AG, as introduced platinated products during this step.
by Blommaert and Saris (1), is a well-designed and sensitive FPLC-method. Before the purification of the platinated DNA adducts on the method. However, various steps in the protocol still needed to
Mono-S column, the pH of the DNA digest was lowered to~3. After injection be improved. The results of our experiments to optimize the of the sample, the column was eluted for 4 min with buffer A to remove the assay and its application on clinical relevant samples are unmodified nucleosides. Then, the adducts were eluted with buffer B for described here.
3 min at 1 ml/min, followed by washing of the column at a flow rate of 2 ml/ min for 3. 0.1 M NaCN was used.
Separation and quantification of the 32 P-labelled dinucleotides 32 P-Postlabelling
The separation of the radioactively labelled products can be performed in two
The mixture of deplatinated products and NaCN could directly ways, either by TLC or HPLC (Scheme I, no 5).
be used for the postlabelling. This was concluded from the Sunnyvale, CA). The dinucleotides GpG, ApG and TpT were labelled with equal efficiency (see below). Therefore, the original amounts of Pt-GG and were diluted to 150 µl with water. Depending on the amount of adducts present, a maximum of 50 µl was injected onto the C 18 -column. Products could be obtained as shown in Figure 1 . In a second method were separated during isocratic elution with 0.1 M KH 2 PO 4 (pH 4.0)/2.5% the labelled products were separated on a C 18 -column by MeOH. Fractions of 0.5 ml were collected and Cerenkov radiation was HPLC (Figure 2 ). This method resulted in elution of 32 pGpG counted. The total amount of each compound was calculated from its total after 6 min, 32 pApG after 9 min, and of 32 pTpT after 19 min.
Separation of the 32 P-labelled dinucleotides
background-corrected radioactivity compared to that of the reference compound TpT, as described for the TLC method, above.
Excess of [γ-32 P]ATP was eluted after 2 min.
Labelling efficiency of the dinucleotides ApG and GpG
To study the kinetics of the labelling reaction, various amounts (0-500 fmol) of the dinucleotide ApG were postlabelled in the presence of 500 fmol TpT and with or without 50 fmol of GpG. After quantification with the TLC method, linear dose- 4 . Correlation between the Pt-GG adduct levels as determined by the ELISA method (using 100 µg DNA) and the 32 P-postlabelling assay (using 10 µg DNA) in salmon sperm DNA treated in vitro with various concentrations of cisplatin (0 to 42.7 nM) for 5 h at 50°C. The R-value is 0.98 (P ϭ 0.00003). Means (adducts/10 7 nucleotides) of the results are given from two separate experiments (Ϯ SD).
obtained after a labelling reaction time of 40 min, however, no differences were seen when the reaction was prolonged to 1 h (data not shown). Also when the amount of [γ-32 P]ATP was limited to 0.2 µl, the substrates were labelled in the same ratio (see Figure 1 ). When the HPLC method was used for the quantification of the adduct levels in cisplatin-treated ovarian cancer cells, also a linear dose-response was observed (see Figure 2) . Comparison of the data obtained with the TLC and HPLC quantification methods indicated that both methods can be used successfully for the determination of small amounts of adducts, i.e. after deplatination and 32 P-postlabelling (data not shown).
Correlation between cisplatin-DNA adduct measurement with the postlabelling assay and the ELISA method
The results after TLC quantification of the postlabelled products were compared with those obtained with the ELISA method of the same DNA samples. For the ELISA method part of the DNA was digested to mononucleotides and 5Ј-phosphorylated adducts (12) . The comparison was made both with in vitro vivo cisplatin-treated HNSCC as well as from tumor, liver and
Results are given as means of three independent experiments Ϯ SD.
kidney samples from cisplatin-treated nude mice bearing human ovarian carcinomas. The ELISA data of the latter will be responses were obtained for 32 pApG ( Figure 3A) . R-values of published in detail elsewhere. The corresponding R-values for 1.0 were found for ApG alone and of 0.99 in combination the Pt-AG and the Pt-GG adducts were 0.77 (P ϭ 0.045) and with 50 fmol GpG. Similar results were found when variable 0.91 (P ϭ 0.042) respectively, indicating a good correlation amounts of GpG were postlabelled ( Figure 3B) , with R-values between these two assays. of 1.0 for GpG alone and of 1.0 for the combination. These
Correlation of postlabelling results with AAS data data also indicate that the presence of other dinucleotides hardly interferes with the labelling efficiency of the dinucleotide of Results obtained with the HPLC-based postlabelling method were compared with those of AAS analysis. For this purpose, interest. Furthermore, the dinucleotides GpG and ApG are shown to be labelled with equal efficiency. These data were part of the DNA isolated from IGROV-1 cells that had . Part of the DNA was used for determination of the total Pt-content by AAS, whereas the adducts Pt-AG and Pt-GG in the other part were deplatinated, 32 P-postlabelled and quantified with the HPLC-based method. Circles, Pt-GG adducts; triangles, Pt-AG adducts; dashed line, total of Pt-GG and Pt-AG adducts. The R-value was 0.99 (P ϭ 0.012) for Pt-AG and 1.0 (P ϭ 0.003) for Pt-GG. Data (in adducts/10 7 nucleotides) are means Ϯ SD of results from at least three independent experiments.
been incubated with various concentrations of cisplatin, was analyzed by postlabelling and another part by AAS. As shown in Figure 6 , highly significant correlations were observed between the total Pt-DNA content (AAS data) and the postlabelling results of the Pt-AG and Pt-GG adducts with R-values of 0.99 (P ϭ 0.012) and 1.0 (P ϭ 0.003), respectively. The total adduct level measured by postlabelling, i.e. Pt-AG plus Pt-GG, was found to be~85% of the overall platination level measured by AAS.
Application of the modified postlabelling assay
The assay described here has already been applied successfully for the determination of adduct levels in white blood cells, buccal cells and tumor biopsies from cisplatin-treated cancer patients. The adduct levels in the blood samples, for example, varied between 14 and 22 adducts/10 7 nucleotides for the Pt-GG and between 5 and 8 for the Pt-AG adducts after treatment with 70 mg/m 2 cisplatin, whereas in a tumor biopsy 93 Pt-GG and 30 Pt-AG adducts/10 7 nucleotides were detected. More data on patient samples will be published elsewhere. The results obtained for the blood cells were in reasonable agreement with those obtained with AAS. In some samples with adduct levels below the detection limit of AAS [~8 adducts/10 7 nucleotides in minimally 200 µg DNA (5)] some adducts could still be detected by postlabelling [1.6 adducts/10 7 nucleotides in 10 µg DNA], which demonstrates the sensitivity of this assay. these, AAS, total adduct levels can be determined. A more sensitive method, in which the various adducts in DNA digests sufficiently from the solvent front during TLC chromatography. Optimal conditions for postlabelling were obtained when the can be measured, was developed by Fichtinger-Schepman and coworkers (12) using competitive ELISA with antisera directed pH of the samples after deplatination was lowered to~8.2 by addition of NaAc (pH 5.4). Using the approach of small against the specific adducts. However, there is a need for an alternative method to quantify Pt-adducts, because of the reaction volumes and adjustment of the pH, it appeared not to be necessary to remove the cyanide, which was still prescribed limited availability of the antisera, the limitation of the use of the antibodies for only cisplatin and carboplatin adducts and by Blommaert and Saris (1) . After the labelling reaction the products were separated by use of either TLC or HPLC (see the relatively large amounts of DNA that are required.
Our initial attempt to determine cisplatin-DNA adduct levels Figures 1 and 2) . With both methods a good separation of 32 pGpG, 32 pApG and 32 pTpT was found, allowing their was to develop a non-radioactive assay analogous to methods described by Jain and Sharma (21) , Kelman et al. (22) and quantification by phosphorimaging or 32 P-counting. Linearity of the labelling was studied by use of reference dinucleotides Sharma et al. (23) , using dansylchloride (5-dimethylaminonaphthalene 1-sulphonyl chloride) to label the phosphate groups ApG and GpG. The results in Figure 3 show a good correlation between the product levels after postlabelling and the starting in adducted nucleotides in order to detect the DNA damage by fluorescence. We tried to dansylate the hydroxyl groups amounts of the dinucleotides as measured by weight (input). The linearity of the method could be confirmed by analysis of in the deoxyribose moieties under non-aqueous conditions (pyridine) analogous to the binding of p-toluenesulphonyl DNA samples isolated from human IGROV-1 ovarian cancer cells treated with various concentrations of cisplatin ( Figure 6 ). chloride to carbohydrates. A major problem of this approach was the poor solubility of the nucleotides. Another approach
The results of the postlabelling assay were compared with those of the ELISA and with data from total DNA platination was labelling with malondialdehyde, a method first described by Moschel and Leonard (24). Recently, the group of Shuker levels measured with AAS. Analyses of salmon sperm DNA and of DNA isolated from (tumor) tissues, both in vitro treated (25) reported the labelling and detection of various alkylguanines by use of phenylmalondialdehyde. In our hands, it with cisplatin, as well as of (tumor) tissues treated in vivo showed good and significant correlations between postlabelling appeared to be possible also to label nucleosides in this way, but the method was not sensitive enough to determine low (with TLC separation) and ELISA data (Figures 4 and 5) for the two adducts Pt-AG and Pt-GG. Although in the same adduct levels as present in biological samples.
In this paper we describe improvements and comparison order, the actual quantities of the adducts were different, especially for the isolated DNA samples ( Figure 5 ). These with conventional methods (ELISA and AAS) of the 32 Ppostlabelling assay for the platinated dinucleotides ApG and differences, however, are not considered to be significant because in Figure 4 the ELISA data are highest and in Figure  GpG The most important ameliorations are the addition of an 5 the postlabelling data are highest. At least part of the apparent discrepancy can be explained by the variation of the ELISA internal standard, a more efficient isolation of the Pt-adducts and a simplification of the deplatination step. Furthermore, for results. A very good and highly significant correlation was found between the levels of the two adducts in the cellular the quantification of the 32 P-labelled products two different methods have been elaborated (see Scheme I for the outline DNA samples as determined by postlabelling (with HPLC separation) and the total platination levels of the original DNA of the whole postlabelling procedure). As the first step in this assay, (isolated) platinated DNA was digested to unmodified samples measured with AAS (see Figure 6 ). The total amount of the two adducts measured by the postlabelling assay, as deoxynucleosides and platinated adducts. For the dephosphorylation by the enzyme alkaline phosphatase a pH of~9 shown in Figure 6 (dashed line), was found to be~85% of the overall platination level of the DNA samples, which is in is required, which is obtained by addition of only 1/100 volume of 1 M Tris/HCl (pH 9.0) to the digestion mixture instead of agreement with previous findings (2,26). The same holds, with a few exceptions, for the observed ratio of 3-4 between the the 1/10 volume as reported before (1) . This reduced volume is very important in view of the need to decrease the pH to Pt-GG and Pt-AG adducts in the cisplatin-treated samples (12, 26) . Combined with the TLC or HPLC separation tech-3 in order to purify the Pt-adducts on the basis of their positive charge on a cation-exchanger. The higher pH of the nique, this postlabelling assay allows a very sensitive determination of adduct levels, viz as low as 1.6 adducts/10 7 DNA digests during this separation step may have been the reason for the rather low recovery of the adducts by these nucleotides in a 10 µg DNA sample. When larger amounts of DNA are analyzed, even lower adduct levels can be detected. authors (1) . The two methods of cation-exchange chromatography presented in this paper, chromatography using the We demonstrated the presence of three adducts per 10 8 nucleotides, which indicates that the sensitivity of the assay is Mono-S and solid-phase extraction on SCX cartridges, are equally effective. An advantage of the Mono-S column is that sufficient for measurements in clinical samples. Because of its high sensitivity, the postlabelling method described in this the amount of DNA applied on the column can be determined directly by comparing the absorbance of the unmodified paper will be very suitable for determining the adduct levels in fine needle aspirates, which often contain not more than nucleosides eluted from the column with that of known amounts of digested salmon sperm DNA. During the elution 10 µg of DNA. Also adduct levels in DNA isolated from buccal cells have already been determined with this assay. from the cation-exchanger, the Pt-adducts were collected in tubes already containing the dinucleotide TpT as an internal Despite the rather small number of cells that is normally obtained (~3ϫ10 5 ), the presence of Pt-GG could be demonstandard and NaCN. The high pH of the resulting solution (~10) prevented digestion of the internal standard by nucleases strated in the buccal mucosal cells of a patient after treatment with 70 mg cisplatin/m 2 (data not shown). In further studies co-eluted with the Pt-adducts. Another dinucleotide which is not supposed to be present in a platinated DNA digests and we will give more attention to this application of the 32 Ppostlabelling assay for Pt-DNA adducts. therefore a possible candidate for an internal standard is CpC. However, the 32 pCpC product could not be separated
In conclusion, with the modified 32 P-postlabelling assay
